NCT06179160 2026-03-16
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Incyte Corporation
Phase 1 Recruiting
Incyte Corporation
Neonc Technologies, Inc.
Karyopharm Therapeutics Inc
Biosplice Therapeutics, Inc.